Please login to the form below

Not currently logged in
Email:
Password:

Abraxane

This page shows the latest Abraxane news and features for those working in and with pharma, biotech and healthcare.

Keytruda monotherapy fails in triple negative breast cancer

Keytruda monotherapy fails in triple negative breast cancer

That approval was a first for checkpoint inhibitors in TNBC, but differed in that it was a combination of Tecentriq and chemotherapy (Celgene’s Abraxane, nab-paclitaxel).

Latest news

More from news
Approximately 14 fully matching, plus 33 partially matching documents found.

Latest Intelligence

  • Immuno-oncology in 2019: the rapid evolution continues Immuno-oncology in 2019: the rapid evolution continues

    An FDA ruling on Tecentriq in combination with carboplatin and nab-paclitaxel (Abraxane) as a first-line treatment for patients with metastatic non-squamous NSCLC (based on the IMpower130 trial) is

  • Chinese biotech’s global ambitions Chinese biotech’s global ambitions

    Meanwhile, BeiGene entered into a strategic global collaboration with Celgene in 2017, gaining the rights to Celgene’s Abraxane Revlimid and Vidaza in China, while Celgene gained an option to market

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Marketing strategy in complex environments

    cells. A good example of this is the combined use of  Abraxane  and  gemcitabine  in the treatment of  metastatic adenocarcinoma  of the pancreas – Abraxane helps to inhibit cancer cell growth, and

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change
...

Infographics